Barbieri, Emiliano http://orcid.org/0000-0003-3148-6608
Maccaferri, Monica
Leonardi, Giovanna
Giacobbi, Francesca
Corradini, Giorgia
Lagreca, Ivana
Barozzi, Patrizia
Potenza, Leonardo
Marasca, Roberto
Luppi, Mario
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (Progetto di Eccellenza Dipartimento MIUR 2017)
Associazione Italiana per la Ricerca sul Cancro (IG 20624-2018)
Associazione Italiana Contro le Leucemie - Linfomi e Mieloma (Charity Dinner Initiative” in memory of Alberto Fontana)
Fondazione IRIS ceramica group
Article History
Received: 21 August 2022
Accepted: 31 August 2022
First Online: 15 September 2022
Declarations
:
: This study was conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local Ethical Committee (CE protocol no. 0036084/21). Informed consent was obtained from all alive patients for being included in the study.
: ML: advisory boards for Novartis, AbbVie, Sanofi, Daiichi-Sankyo, Grifols; honoraria for lectures from Gilead Sci, MSD, Jazz Pharma; travel grant from Gilead Sci.RM: honoraria from AbbVie, Janssen, Astra Zeneca.The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.